JUN 17, 2016 5:05 PM PDT

Federal Safety Board to Consider First Use of CRISPR on Human

WRITTEN BY: Carmen Leitch
A trial of the CRISPR/Cas9 gene editing technology has been proposed for use in a human patient. The National Institute of Health Recombinant DNA Advisory Committee (RAC) formed 40 years ago to oversee and create guidelines for the use of recombinant DNA technology in NIH funded studies. It recently made a few amendments to the guidelines which limited submissions of human gene transfer protocols (experiments in which humans are given some kind of nucleic acid like natural or synthetic RNA or DNA) to only exceptional cases. One such case will be discussed at the June 21-22 meeting of the RAC. 
An overview of CRISPR technology, when used to affect cells in culture, from Wikipedia
The proposal is to use the immune system of a patient to battle cancer cells. White blood cells would be removed from a person suffering from a cancer such as myeloma, melanoma, or sarcoma. The white blood cells would be altered using CRISPR. Upon returning the altered cells to the patient, they will target and attack the tumor cells.

CRISPR has taken the world of molecular biology by storm since its creation in 2012. It allows for the target and editing of genes in a very precise way. It’s a relatively straightforward and low cost tool that has been broadened and improved since its invention. “Researchers in the field of gene transfer are excited by the potential of utilizing CRISPR/Cas9 to repair or delete mutations that are involved in numerous human diseases in less time and at a lower cost than earlier gene editing systems,” Carrie Wolinetz, associate director of science policy at the NIH, commented in a blog post that revealed the submission of the new protocol.

The plan has been submitted for review by the University of Pennsylvania. That university has already had some experience in this area. They were part of developing a therapy in which a patient suffering from a deadly form of leukemia was successfully treated using genetic engineering on the patient’s white blood cells. These are the same cells to be modified in the proposed treatment. Normally they attack bacteria, and just require a few changes so they will go after other cell types, like tumor cells. In this video below, white blood cells of the immune system are seen attacking cancer after being reprogrammed.

There are plenty of risks associated with these kinds of treatments, and with anything so new there could be unintended and unforeseen consequences. “While the application of new gene editing technologies in this field has great potential to improve human health, it is not without concerns,” continued Wolinetz.

The upcoming meeting of the RAC will be available for public viewing online through the NIH videocast. For more information about the meeting, check the Office of Science Policy website.

To learn more about more about CRISPR/Cas9 gene editing technology, watch the video below in which one of the creators of the tool, Jennifer Doudna, a Professor of the Departments of Chemistry and of Molecular and Cell Biology at University of California, Berkeley, and an Investigator of the Howard Hughes Medical Institute, explains it.


Sources: National Institute of Health, MIT Technology Review
About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 10, 2019
Immunology
DEC 10, 2019
T Cell Subset Uniquely Equipped to Target IBD
A specialized form of T cell emerges as a new focus for gastrointestinal health research, specifically in the context of inflammatory bowel disease (IBD) f...
DEC 12, 2019
Cell & Molecular Biology
DEC 12, 2019
Newly Identified Small Proteins Could Have a Big Impact
While the human genome has been sequenced, there are plenty of parts of it that we don't know much about....
JAN 09, 2020
Cell & Molecular Biology
JAN 09, 2020
Acidic Stomach Environment May Worsen Microbial Pathogenicity
The acids of the stomach may not pose a problem for bad bugs....
FEB 05, 2020
Cell & Molecular Biology
FEB 05, 2020
Gut Bacteria Affect How the Colon Moves
The contraction and relaxation of muscles in the wall of the colon helps move food along and can become dysfunctional....
FEB 07, 2020
Genetics & Genomics
FEB 07, 2020
Mutations That Lead to Cancer May Occur Decades Before Diagnosis
As our cells age or divide, errors can accumulate in the genome they carry, which can lead to cancer, and a variety of environmental and genetic factors ca...
FEB 09, 2020
Cell & Molecular Biology
FEB 09, 2020
Learning More About X Chromosome Inactivation
The X chromosome carries a thousand genes, so in females, one of the X chromosomes must be silenced to avoid serious developmental consequences....
Loading Comments...